Karen E. Hurley
PhD. in Clinical Psychology, Temple University
Clinical Internship, University of Medicine & Dentistry-Newark
Post-Doctoral Fellowship, Behavioral Oncology, Mt. Sinai School of Medicine
1. Hurley K, Rubin L, Werner-Lin A, Sagi M, Kemel Y, Stern R, Phillips A, Cholst I, Kauff N, Offit K. Incorporating information about pre-implantation genetic diagnosis into discussions about testing and risk-management for BRCA1/2 mutations: A qualitative study of patient preferences. Cancer 2012; Jun 26. doi: 10.1002/cncr.27695. [Epub ahead of print].
2. Roussi P, Sherman K, Miller S, Hurley K, Daly M, Godwin A, Buzaglo J, Wen K. Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques. Psychol Health 2011;26:1327-43.
3. DuHamel K, Mosher C, Winkel G, Labay L, Rini C, Meschian Y, Austin J, Greene P, Lawsin C, Rusiewicz A, Grosskreutz C, Isola L, Moskowitz C, Papadopoulos E, Rowley S, Scigliano E, Burkhalter J, Hurley K, Redd W. Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce PTSD and distress symptoms after hemopoietic stem cell transplant. J Clin Oncol 2010;28:3754-61
4. McLaughlin S, Wright MJ, Morris K, Sampson M, Brockway J, Hurley K, Reidel E, Van Zee K. Lymphedema in 936 women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection II: Patient perceptions and precautionary behaviors. J Clin Oncol 2008;26:5220-26.
5. Offit K, Sagi M, Hurley KE. Preimplantation genetic diagnosis for cancer syndromes: A new challenge for preventive medicine. JAMA. 2006 Dec 13;296(22):2727-30.
6. Miller SM, Shoda Y, Hurley K. Applying cognitive-social theory to health-protective behavior: Breast self-examination in cancer screening. Psychol Bull 1996; 119:70-94.
FORCE (Facing Our Risk of Cancer Empowered): www.facingourrisk.org
Bright Pink: www.brightpink.org